Efficacy of Unstable Shoes for Instability and Lumbopelvic Pain

Efficacy of Masai Barefoot Technology (MBT) for Decreasing Pain and Improvement of Lumbopelvic Pain

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03065270

Enrollment

Registered

2017-02-27

Start date

2011-09-30

Completion date

2015-05-31

Last updated

2017-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbopelvic Postpartum Pain

Brief summary

During pregnancy, pregnant women adopt an atypical pattern position with the intention to maintain stability and balance.These postural changes can cause instability at the level of the sacroiliac joint with painful condition during pregnancy and postpartum. 40 % of women have postpartum lumbopelvic instability. In 17 % of cases the lumbopelvic pain is perpetuated. Another alteration influenced by the gestational status and progress of labor is urinary incontinence (UI). The mechanism developed by Masai Barefoot Technology (MBT) provides an unstable base. Some studies reviewed, indicate that this shoe increases muscle activity, contributes to the decrease of joint overload and thereby, decreases pain. Objective To compare the efficacy of shoes with unstable sole MBT®, over the use of conventional sports shoes, in primiparous women with lumbopelvic postpartum pain. Material and Methods Randomized clinical trial. 24 postpartum women from the Gynecology Service of the Hospital Universitario Madrid Chiron were included in the study. The subjects were randomly divided into experimental and control group.

Interventions

OTHERUse unstable shoes Masai Barefoot Technology (MBT)

Use of unstable shoes during 9 weeks, at least four hours per day.

OTHERUse conventional sport shoes

Use of conventional sport shoes during 9 weeks, at least four hours per day.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Investigator)

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

Primparous women. * Postpartum, between 8-12 weeks after the date of delivery. * With lumbopelvic pain and positive diagnostic tests of sacroiliac pain * Women with ambulation ability.

Exclusion criteria

* Presence of vaginal prolapses. * Be receiving another treatment for the alteration that concerns us, pharmacological or any other type of therapy. * Neuromuscular alterations.

Design outcomes

Primary

Measure	Time frame	Description
Pain	9th week	Sacroiliac pain provocation test.

Secondary

Measure	Time frame	Description
Pelvic Stability	9th week	Podiatric Stabilometry.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026